Media coverage about Fonar (NASDAQ:FONR) has trended positive recently, according to Accern Sentiment Analysis. Accern rates the sentiment of media coverage by monitoring more than 20 million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Fonar earned a media sentiment score of 0.25 on Accern’s scale. Accern also gave press coverage about the medical equipment provider an impact score of 48.0434255092302 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.
Shares of Fonar stock traded down $0.40 during trading on Friday, reaching $27.60. The company’s stock had a trading volume of 35,283 shares, compared to its average volume of 33,284. The stock has a market capitalization of $173.54, a price-to-earnings ratio of 9.23 and a beta of 2.07. Fonar has a fifty-two week low of $17.20 and a fifty-two week high of $33.90.
Fonar (NASDAQ:FONR) last announced its earnings results on Monday, February 12th. The medical equipment provider reported $0.70 EPS for the quarter. The business had revenue of $20.17 million for the quarter. Fonar had a net margin of 23.44% and a return on equity of 23.26%.
Fonar Corporation, together with its subsidiaries, engages in the design, manufacture, sale, and servicing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases, abnormalities, and other medical conditions and injuries. It operates in two segments, Medical Equipment, and Physician Management and Diagnostic Services.
Receive News & Ratings for Fonar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fonar and related companies with MarketBeat.com's FREE daily email newsletter.